Drugs in pregnancy: acknowledging challenges--finding solutions.
Koren
Gideon
G
The Motherisk Program, Toronto and Ivey Chair in Molecular Toxicology, University of Western Ontario. gkoren@sickkids.ca
MacLeod
Stuart
S
Davis
Donald
D
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002170:Canada; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000592:standards / Q000639:trends; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D005905:Glyburide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018579:Patient Selection; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000517:prevention & control; D011264:Pregnancy Trimesters
D000928:Antidepressive Agents; D005905:Glyburide